3.30
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? - Kalkine Media
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation - TradingView
Wave Life Sciences stock hits a 52-week low at USD 4.20 - AD HOC NEWS
Wave Life Sciences Names Monika Vnuk Chief Business Officer - citybiz
Wave Life Sciences appoints Monika Vnuk as chief business officer By Investing.com - Investing.com Australia
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - The Manila Times
Wave Life Sciences Appoints Monika Vnuk as Chief Business Officer - Quiver Quantitative
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - GlobeNewswire
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - GlobeNewswire
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - Yahoo Finance
Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com Nigeria
Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com Canada
Wave Life Sciences at Cantor conference: RNA editing gains traction - investing.com
Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com UK
Wave Life Sciences stock holds steady ahead of Cantor healthcare conference appearance - ad-hoc-news.de
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - GlobeNewswire
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - Yahoo Finance
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Wave Life Sciences stock trades quietly as investors focus on recent clinical progress - ad-hoc-news.de
WAVE Life Sciences (NASDAQ:WVE) Downgraded by Zacks Research to "Hold" - MarketBeat
Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - Simply Wall Street
Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st
Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st
Wave Life Sciences targets fat loss without sacrificing muscle - Longevity.Technology
Insiders Sold Wave Life Sciences Prematurely At US$13.64 With Stock Trading Higher - Moomoo
Wave Life Sciences (WVE) Pulls Back 5.2% to $5.13 as Support Holds at $4.87Thematic ETF Flow - vinanet.vn
Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan
Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones - Stock Traders Daily
Wave Life Sciences, Inc.: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com
Wave Life Sciences, Inc.: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc. Stock (WVE)Quote Nasdaq - marketscreener.com
Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Q2 2026 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
Wave Life Sciences Ltd.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043 - marketscreener.com
WVE Q2 2026 Earnings: Wider-than-Expected Loss of $0.34 per Share Highlights Pipeline InvestmentProfit Growth Outlook - https://www.dars.gov.et/
Wave Life Sciences (WVE) Director Adrian Rawcliffe Sells 12,700 Shares, Reducing Stake to Zero - GuruFocus
WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares - MarketBeat
Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan - Stock Titan
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Yahoo Finance
Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales - simplywall.st
Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026) - Stock Titan
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Canada
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com South Africa
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Nigeria
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):